Latest Close
$6.65
News
ADXN
Addex Therapeutics Ltd News
This news view pulls recent coverage and headlines tied to ADXN.
1y Change
-$1.37 (-17.08%)
Market Cap
$8,417,863.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire • Apr 30, 2026
Read articleAddex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
GlobeNewswire • Apr 29, 2026
Read articleAddex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026
GlobeNewswire • Apr 23, 2026
Read articleAddex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
GlobeNewswire • Apr 21, 2026
Read article